VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $101,400,000 | +485.3% | 4,363,330 | +300.9% | 0.03% | +250.0% |
| Q1 2018 | $17,323,000 | -71.0% | 1,088,470 | -62.1% | 0.01% | -78.9% |
| Q4 2017 | $59,660,000 | +34.6% | 2,871,121 | -7.1% | 0.04% | +26.7% |
| Q3 2017 | $44,308,000 | +77.2% | 3,092,190 | +114.0% | 0.03% | +66.7% |
| Q2 2017 | $25,000,000 | +406.3% | 1,445,248 | +222.7% | 0.02% | +350.0% |
| Q1 2017 | $4,938,000 | -44.5% | 447,910 | -27.0% | 0.00% | -42.9% |
| Q4 2016 | $8,905,000 | -30.5% | 613,513 | +17.6% | 0.01% | -22.2% |
| Q3 2016 | $12,806,000 | +227.1% | 521,742 | +168.3% | 0.01% | +200.0% |
| Q2 2016 | $3,915,000 | -85.2% | 194,448 | -80.7% | 0.00% | -85.0% |
| Q1 2016 | $26,480,000 | -89.5% | 1,006,962 | -59.3% | 0.02% | -88.5% |
| Q4 2015 | $251,420,000 | +330.3% | 2,473,425 | +655.1% | 0.17% | +286.7% |
| Q3 2015 | $58,425,000 | -19.2% | 327,560 | +0.6% | 0.04% | -2.2% |
| Q2 2015 | $72,319,000 | +7.2% | 325,558 | -4.2% | 0.05% | +9.5% |
| Q1 2015 | $67,477,000 | -54.5% | 339,758 | -67.2% | 0.04% | -53.8% |
| Q4 2014 | $148,301,000 | -20.5% | 1,036,308 | -27.1% | 0.09% | -21.6% |
| Q3 2014 | $186,511,000 | +425.9% | 1,421,614 | +405.5% | 0.12% | +383.3% |
| Q2 2014 | $35,463,000 | +73.5% | 281,208 | +80.6% | 0.02% | +60.0% |
| Q1 2014 | $20,443,000 | -16.6% | 155,688 | -25.9% | 0.02% | -16.7% |
| Q4 2013 | $24,514,000 | +84.2% | 210,096 | +62.6% | 0.02% | +80.0% |
| Q3 2013 | $13,310,000 | – | 129,172 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |